- Kimberly-Clark’s preliminary third-quarter net sales are reported at $4.13 billion, slightly above the estimated $4.1 billion.
- The preliminary adjusted earnings per share (EPS) is reported at $1.70.
- Preliminary adjusted operating profit (OP) is $677 million, compared to the estimated $674.9 million.
- The company maintains its 2026 outlook, which aligns with previous forecasts.
- Kimberly-Clark anticipates its year-over-year organic sales growth to be approximately 100 basis points lower than its weighted average category growth across its competing markets.
- The company expects mid-single-digit adjusted operating profit growth on a constant-currency basis for 2026.
- Analyst recommendations for Kimberly-Clark include 6 buys, 9 holds, and 1 sell.
Kimberly Clark on Smartkarma
Kimberly Clark is under bullish analyst coverage on Smartkarma, with Baptista Research publishing insightful reports on the consumer health giant. In one report titled “Kimberly-Clark’s Kenvue Acquisition: Could It Reshape The Consumer Health Giant?“, the analyst highlights the company’s resilience in the face of global challenges. Despite headwinds like consumer pressure and moderating category growth, Kimberly-Clark reported positive volume and mix growth for the tenth consecutive quarter, supported by strong productivity gains and successful cost improvements.
In another report by the same analyst titled “Kimberly-Clark: 6% Productivity Gains May Not Be Enough For Back-Half Cost Pressure!“, the focus shifts to the company’s strategic transformation and solid organic sales growth. The report emphasizes the success of Kimberly-Clark’s innovation efforts in key areas like Baby Care and Women’s Health, driving positive volume growth. However, concerns are raised about cost pressures in the second half of the year, despite the company’s 6% productivity gains and disciplined promotional strategies.
A look at Kimberly Clark Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 5 | |
| Growth | 3 | |
| Resilience | 3 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 3.2 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Kimberly-Clark Corporation, a global health and hygiene company known for its consumer products like diapers, tissues, and paper towels, has received a high rating for its dividend stability. With a top score in this category, investors can rely on consistent dividend payouts from the company. While the overall outlook for Kimberly Clark is positive, there are areas for potential growth and improvement, as seen in its scores for value, growth, resilience, and momentum.
Despite not scoring the highest in all categories, Kimberly-Clark shows promise for long-term investment. The company’s strong focus on dividends, combined with its diverse range of products sold worldwide, positions it well for stability and growth in the market. Investors looking for a reliable income stream and a company with a solid product portfolio may find Kimberly-Clark an appealing long-term investment opportunity.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
